The risk of atherosclerotic vascular disease in subjects with xanthomatosis

Acta Medica Scandinavica
|October 1, 1975
PubMed

Insights

Xanthomatosis significantly increases the risk of early-onset cardiovascular disease, particularly coronary heart disease (CHD). Patients experience premature mortality, with reduced life expectancy compared to the general population.

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Background:

  • Xanthomatosis is a rare condition characterized by the deposition of lipids in tissues.
  • Atherosclerotic vascular disease is a known complication, but its specific impact on morbidity and mortality in xanthomatosis requires further investigation.

Purpose of the Study:

  • To investigate the morbidity and mortality patterns in patients with xanthomatosis.
  • To determine the primary manifestations and age of onset of atherosclerotic vascular disease in this cohort.
  • To assess the impact of xanthomatosis on overall survival and cardiovascular death rates.

Main Methods:

  • Retrospective analysis of 172 males and 164 females diagnosed with xanthomatosis.
  • Detailed examination of initial clinical manifestations, focusing on coronary heart disease (CHD) and other atherosclerotic events.
  • Comparison of mortality data with the general Norwegian population.

Main Results:

  • Coronary heart disease (CHD) was the most frequent initial manifestation, with angina pectoris and myocardial infarction being common.
  • Mean age for first symptoms of atherosclerotic vascular disease was 49 for men and 56 for women.
  • Patients with xanthomatosis exhibited a significantly increased risk of cardiovascular death, including sudden deaths, with a mortality rate approximately double that of the general population and reduced life expectancy.

Conclusions:

  • Xanthomatosis is strongly associated with premature atherosclerotic vascular disease and significantly increased cardiovascular mortality.
  • Early recognition and management of xanthomatosis are crucial for mitigating severe cardiovascular complications and improving patient survival.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...